- Home
- VERO vs DRMA Comparison
VERO vs DRMA Comparison
Compare VERO & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- DRMA
- Stock Information
- Founded
- VERO N/A
- DRMA 2014
- Country
- VERO Canada
- DRMA United States
- Employees
- VERO N/A
- DRMA N/A
- Industry
- VERO Medical/Dental Instruments
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- VERO Health Care
- DRMA Health Care
- Exchange
- VERO Nasdaq
- DRMA Nasdaq
- Market Cap
- VERO 2.2M
- DRMA 2.2M
- IPO Year
- VERO N/A
- DRMA 2021
- Fundamental
- Price
- VERO $0.36
- DRMA $1.33
- Analyst Decision
- VERO
- DRMA Strong Buy
- Analyst Count
- VERO 0
- DRMA 1
- Target Price
- VERO N/A
- DRMA $6.00
- AVG Volume (30 Days)
- VERO 327.8K
- DRMA 230.6K
- Earning Date
- VERO 11-13-2024
- DRMA 11-13-2024
- Dividend Yield
- VERO N/A
- DRMA N/A
- EPS Growth
- VERO N/A
- DRMA N/A
- EPS
- VERO N/A
- DRMA N/A
- Revenue
- VERO $67,200,000.00
- DRMA N/A
- Revenue This Year
- VERO N/A
- DRMA N/A
- Revenue Next Year
- VERO $4.39
- DRMA N/A
- P/E Ratio
- VERO N/A
- DRMA N/A
- Revenue Growth
- VERO N/A
- DRMA N/A
- 52 Week Low
- VERO $0.28
- DRMA $1.00
- 52 Week High
- VERO $2.22
- DRMA $8.66
- Technical
- Relative Strength Index (RSI)
- VERO 48.64
- DRMA 51.81
- Support Level
- VERO $0.33
- DRMA $1.30
- Resistance Level
- VERO $0.40
- DRMA $1.48
- Average True Range (ATR)
- VERO 0.06
- DRMA 0.12
- MACD
- VERO -0.00
- DRMA 0.00
- Stochastic Oscillator
- VERO 16.03
- DRMA 49.66
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.